Vitrolife AB
STO:VITR

Watchlist Manager
Vitrolife AB Logo
Vitrolife AB
STO:VITR
Watchlist
Price: 221.4 SEK 4.04% Market Closed
Market Cap: 30B SEK
Have any thoughts about
Vitrolife AB?
Write Note

Vitrolife AB
Other Long-Term Assets

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Vitrolife AB
Other Long-Term Assets Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Other Long-Term Assets CAGR 3Y CAGR 5Y CAGR 10Y
Vitrolife AB
STO:VITR
Other Long-Term Assets
kr154m
CAGR 3-Years
108%
CAGR 5-Years
123%
CAGR 10-Years
N/A
Biogaia AB
STO:BIOG B
Other Long-Term Assets
kr6m
CAGR 3-Years
4%
CAGR 5-Years
-7%
CAGR 10-Years
N/A
Bonesupport Holding AB
STO:BONEX
Other Long-Term Assets
kr231.7m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Probi AB
STO:PROB
Other Long-Term Assets
kr9.9m
CAGR 3-Years
522%
CAGR 5-Years
16%
CAGR 10-Years
N/A
Swedish Orphan Biovitrum AB (publ)
STO:SOBI
Other Long-Term Assets
kr1.1B
CAGR 3-Years
31%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
BioArctic AB
STO:BIOA B
Other Long-Term Assets
kr567k
CAGR 3-Years
8%
CAGR 5-Years
25%
CAGR 10-Years
N/A
No Stocks Found

Vitrolife AB
Glance View

Market Cap
30B SEK
Industry
Biotechnology

Vitrolife AB engages in the development, manufacture, and sale of products and systems for the preparation, cultivation, and storage of human cells, tissue, and organs. The company is headquartered in Goeteborg, Vastra Gotalands and currently employs 427 full-time employees. The company went IPO on 2001-06-26. The Company’s product portfolio comprises G-RINSE, which is a solution for rinsing of contact materials, EmbryoGlue, which is a human albumin recombinant, ASP, which is a solution for oocyte retrieval and rinsing, and Semen VTS, which is a viscosity treatment system, among others. The company also provides a range of procedural solutions for sperm preparation, vitrification, embryo transfer and oocyte retrieval, such as temperature control, condition control, gamete-safe labware and embryo support. The firm is active in Australia, China, France, Italy, Japan, the United States and the United Kingdom, among others, and conducts its business through a number of subsidiaries, such as Vitrolife Ltd., Vitrolife Pty Ltd., and A.T.S. Srl.

VITR Intrinsic Value
139.61 SEK
Overvaluation 37%
Intrinsic Value
Price

See Also

What is Vitrolife AB's Other Long-Term Assets?
Other Long-Term Assets
154m SEK

Based on the financial report for Sep 30, 2024, Vitrolife AB's Other Long-Term Assets amounts to 154m SEK.

What is Vitrolife AB's Other Long-Term Assets growth rate?
Other Long-Term Assets CAGR 5Y
123%

Over the last year, the Other Long-Term Assets growth was 13%. The average annual Other Long-Term Assets growth rates for Vitrolife AB have been 108% over the past three years , 123% over the past five years .

Back to Top